Safeguard Scientifics Inc

Safeguard Scientifics Inc exhibits a strong capital structure with a current ratio of 22.67, indicating a high level of liquidity and the ability to cover short-term liabilities many times over. The company has no long-term debt, and its cash and equivalents amount to $19.4 million, which is a significant portion of its total assets of $46.2 million. This liquidity position is further supported by a debt-to-equity ratio of 0.0, suggesting a conservative capital structure with no leverage. Profitability metrics for Safeguard Scientifics Inc are negative, with a return on equity (ROE) of -15.41% and a return on assets (ROA) of -14.52%. These figures indicate that the company is not generating returns for its shareholders and is underperforming relative to industry norms. The negative operating income of $1.23 million and net income of -$6.71 million further underscore the company's current unprofitability. The company's revenue is derived from a diversified portfolio of technology and life sciences businesses, though specific segment details are not disclosed in the available data. Geographically, the company's exposure is not explicitly outlined, but its operations are likely concentrated in the United States given its listing and primary market. Looking ahead, the company's growth trajectory is uncertain. The current fiscal year is expected to show a continuation of the negative trends, with no significant improvement in operating cash flow, which was -$1.00 million in the latest period. The lack of positive cash flow and the absence of long-term debt suggest that the company is not currently expanding through capital-intensive projects or acquisitions. Risk factors for Safeguard Scientifics Inc include its unprofitable operations and the potential for continued negative returns on equity and assets. The company's liquidity is strong, but its profitability is a concern. There is no immediate dilution risk, as the number of shares outstanding has not changed between basic and diluted shares. The company has not made any recent adjustments to its valuation metrics, and there are no filing-based liquidity or dilution flags. Recent events for Safeguard Scientifics Inc include the latest financial reporting period, which shows a continuation of the company's unprofitable operations. There are no recent filings or transcripts indicating significant changes in strategy or operations. The company's focus remains on managing its portfolio of investments and subsidiaries, with no immediate plans for major restructuring or expansion.